Navigation Links
H1N1 pandemic points to vaccine strategy for multiple flu strains
Date:1/10/2011

"

When the study began, there was no vaccine for the novel 2009 H1N1 strain. The researchers hoped to use the antibodies from patients who recovered as therapy for those who were severely ill with this emerging virus.

The researchers began by analyzing antibody responses from nine patients recruited through the Hope Clinic, the clinical division of the Emory Vaccine Center. In these patients, ages 21 to 45 years old, the virus caused a range of illness, from mild to life-threatening disease.

The researchers identified white blood cells from the patients that made antibodies against the virus, then isolated antibody genes from individual cells. They used the genes to produce antibodiesa total of 86 varietiesand then tested which flu strains the antibodies reacted against.

Five antibodies isolated by the team could bind all the seasonal H1N1 flu strains from the last decade, the devastating "Spanish flu" strain from 1918, plus a potentially lethal H5N1 avian flu strain.

This indicated that "while the flu changes from year to year, some core elements have been consistent for nearly a century," said Wilson.

The cross-reactive antibodies were produced by highly mutated antibody genes. These antibodies appear to have been produced by white blood cells that had been exposed to influenza in previous years and were reactivated by a new viral infection. As the antibody genes, developed to combat one strain, adapted to a new infection, they continued to mutate, increasing their affinity for certain key targets present on both strains.

Half of the cross-reactive antibodies the team identified attached to the virus's "stalk" region, a sort of biochemical drill-bit the virus uses to enter cells. Because this part of the virus doesn't change as much as other regions, scientists have proposed to make it the basis for a vaccine that could provide broader protection.

"Previously, this type of broadly protective
'/>"/>

Contact: John Easton
john.easton@uchospitals.edu
773-702-6241
University of Chicago Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Rethinking who should be considered essential during a pandemic flu outbreak
2. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
3. New World post-pandemic reforestation helped start Little Ice Age, say Stanford scientists
4. Swine flu genes dissimilar to past pandemics
5. 1 in 6 health workers wont report in flu pandemic -- study by Ben-Gurion U. researchers
6. K-State researcher, collaborators study virulence of pandemic H1N1 virus
7. Pandemic flu can infect cells deep in the lungs, says new research
8. Excellence in Paediatrics conference line-up includes WHO and CDC pandemic speakers
9. £7.5 million ($12.6 million) collaborations lead UK research communitys response to H1N1 pandemic
10. Short-term school closures may worsen flu pandemics, Pitt study finds
11. UT Southwestern scientist begins to unravel what makes pandemic H1N1 tick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Inc. , a market leader of iris-based identity authentication solutions, ... the new role of Senior Vice President of Mobile and ... platforms and wearable solutions for EyeLock,s technologies. Gerber brings more ... industry to his role at EyeLock, with expertise in human ...
(Date:12/24/2014)... YORK , Dec. 23, 2014  Since its launch in December ... people to eliminate the pain of trying to remember their ... own biometrics fused to their smartphones. To assist people who ... , the company that created 1U and focuses on redefining ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides ... and fingerprinting markets. Watermarking aims to control and ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3The Global Watermarking and Fingerprinting Markets 2
... American Society for Microbiology (ASM) sanofi-aventis U.S. Award ... WWAMI Regional Center of Excellence for Biodefense and ... an unrestricted grant from sanofi-aventis U.S., this award ... his professional life, Dr. Stamm has worked with ...
... of biosolids (treated municipal sewage sludge) is a common ... nutrients and organic matter. However, the presence of detectable ... farmland application may result in accumulation of dioxins in ... chain because several congeners of dioxins have extremely high ...
... Spanish . Cancer is a disease characterised ... give higher proliferative capacity to cancer cells, but they ... research group led by Dr. Jos Carlos Fernndez-Checa in ... (IIBB-CSIC), a centre linked to the Institut d,Investigacions Biomdiques ...
Cached Biology News:Dioxin risk in soil and plant tissues after long-term biosolids application 2Mitochondrial cholesterol makes response to chemotherapy difficult in hepatic cancer 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Protocol Networks ... The growing team of brand-neutral, independent consultants, Protocol Networks ... Rogers explained that over the years, his company has ... Moroso, Town of Plainfield, as well as others. With ...
(Date:1/22/2015)... 2015 Controlled Substance Compliance Services (CSCS), ... companies check the legal requirements around using controlled substances ... , As their international operations expand and become ... solutions built as a result of the first phase ...
(Date:1/22/2015)... PALO ALTO, Calif. , Jan. 22. 2015  Varian Medical ... equipment and software, has been honored for its commitment to ... most sustainable companies. Varian is the highest ranked healthcare equipment ... ranking, announced today during the World Economic Forum at ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: ... areas, announced the closing of an underwritten public offering of ... to an aggregate 3,500,000 shares of common stock, at an ... The warrants have a per share exercise price of $5.00, ...
Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 2Global Compliance Service for Controlled Substances to Expand to China 2Varian Honored Among World's 100 Most Sustainable Corporations 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... Introduction , ... algorithms for monitoring GeneChip ® expression data. These ... designed to accommodate the typical distribution of data found ... statistical techniques and are optimized to accommodate advancements in ...
... Chromatography and Mass Spectrometry Application Report , ... serum Acepromazine , Gargi Choudhary, Thermo ... Wayne Skinner and Scott Stanley, University of California, Davis ... Acepromazine is widely used as a sedative in horses. ...
... Mass Spectrometry Application Note , Kevin ... Thermo Electron Corporation, Somerset, NJ, USA , ... Acrylamide has been identified as a potential ... industrial chemical, but acrylamide was recently discovered to be present at significant ...
Cached Biology Technology:New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 2New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 3New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 4New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 5New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays 6Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 2Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 3Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer 4Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 2Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 3Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 4Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 5Quantitation of Acrylamide in Food Samples on the Finnigan TSQ Quantum Discovery by LC/APCI-MS/MS 6
Donor Horse Serum US Origin...
jub, ajuba homolog (Xenopus laevis)...
Size & Applications: 100 ul (2 mM). Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.) Storage Temp.: -20C Shelf Life: 6-12 month...
NM522 contains an F episome, which is required for production of ssDNA and for blue/white color selection. To maintain the F, NM522 should be grown on minimal (M-9) medium....
Biology Products: